CM
MRTX

Caption Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Caption Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-104,100
Closed -$6.12M – 1786
2023
Q4 		$6.12M Buy
104,100
+22,000
+27% +$1.24M 0.08% 279
2023
Q3 		$3.58M Buy
+82,100
New +$2.93M 0.06% 415
2023
Q1 		– Sell
-128,000
Closed -$5.8M – 1683
2022
Q4 		$5.8M Buy
128,000
+28,000
+28% +$1.81M 0.09% 269
2022
Q3 		$6.98M Buy
100,000
+54,000
+117% +$4M 0.1% 255
2022
Q2 		$3.09M Buy
+46,000
New +$2.93M 0.04% 526
2022
Q1 		– Sell
-137,900
Closed -$20.2M – 2081
2021
Q4 		$20.2M Sell
137,900
-92,200
-40% -$14.3M 0.23% 92
2021
Q3 		$40.7M Buy
+230,100
New +$37M 0.47% 28
2021
Q2 		– Sell
-27,500
Closed -$4.71M – 1641
2021
Q1 		$4.71M Sell
27,500
-22,500
-45% -$4.45M 0.1% 257
2020
Q4 		$11M Sell
50,000
-47,900
-49% -$10.4M 0.25% 108
2020
Q3 		$16.3M Buy
97,900
+32,900
+51% +$4.5M 0.38% 48
2020
Q2 		$7.42M Sell
65,000
-53,200
-45% -$5.16M 0.25% 104
2020
Q1 		$9.08M Sell
118,200
-76,100
-39% -$6.82M 0.51% 35
2019
Q4 		$25M Buy
194,300
+111,200
+134% +$10.7M 0.84% 17
2019
Q3 		$6.47M Sell
83,100
-174,100
-68% -$16.3M 0.34% 78
2019
Q2 		$26.5M Buy
257,200
+257,100
+257,100% +$20M 1.33% 7
2019
Q1 		$7K Buy
+100
New +$6.8K ﹤0.01% 539
2018
Q4 		– Sell
-26,700
Closed -$1.26M – 672
2018
Q3 		$1.26M Buy
+26,700
New +$1.49M 0.07% 312

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's MRTX Position: Q1 2024 in Review

Caption Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36,600 shares — an estimated $2.15M sold.

Caption Management first reported a position in MRTX in Q1 2019 and held it in 14 quarters. The position peaked at $15.2M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Caption Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 36,600 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.15M.
  • Caption Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Caption Management's Mirati Therapeutics, Inc. Common Stock position peaked at $15.2M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.